SAGE — Sage Therapeutics Share News
0.000.00%
Last trade - 00:00- $544.97m
- $121.11m
- $41.24m
U.S. STOCKS ON THE MOVE-Comcast, Wix.com, Flex
Sage Therapeutics declines after stopping development of rare disease drug
Sage Therapeutics scraps development of rare disease drug after it fails mid-stage study (updated)
Sage Therapeutics' rare disease drug fails mid-stage study
Brief: Sage Therapeutics Announces Topline Results from the Phase 2 DIMENSION Study of Dalzanemdor (SAGE-718)
Brief: Sage Therapeutics CFO Kimi Iguchi resigns from position
Sage Therapeutics Inc Reports Results For The Quarter Ended In January 1: Earnings Summary
Brief: SAGE Therapeutics Q3 Product Revenue USD 843 Thousand
Sage Therapeutics Inc Expected To Post A Loss Of $1.53 A Share: Earnings Preview
U.S. STOCKS ON THE MOVE-Avery Dennison, Snap-On, Avadel Pharma
U.S. STOCKS ON THE MOVE-Avery Dennison, Snap-On, Avadel Pharma
Sage to lay off more than half of R&D team, shares fall
Brief: SAGE Therapeutics Approved Separation Of CFO Kimi Iguchi And Anne Cook, Senior VP, General Counsel, And Secretary
Brief: SAGE Therapeutics Says To Reduce Workforce By About 33%
Sage Therapeutics to lay off more than 165 employees (updated)
Sage Therapeutics to lay off more than 165 employees
U.S. RESEARCH ROUNDUP-Autozone, State Street, UnitedHealth
U.S. STOCKS ON THE MOVE-Copper miners, PepsiCo, Casinos
Sage Therapeutics halts Alzheimer’s drug development after trial fails; shares tank (updated)